check_circleStudy Completed

Magnetic Resonance Imaging

Bayer Identifier:
Trial_202-14_88493
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Gadopentetate Dimeglumine as an magnetic resonance imaging (MRI) contrast agent in pediatric patients

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

3 - 18 Years

Trial summary

Enrollment Goal
20
Trial Dates
May 1987 - October 1987
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Open-Label Study of Gadopentetate Dimeglumine as an magnetic resonance imaging (MRI) contrast agent in pediatric patients presenting with symptoms of central nervous system lesions
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.